updated 2/14/2013 8:15:32 AM ET 2013-02-14T13:15:32

(Reuters) - Merck & Co on Thursday said it has agreed to pay $688 million to settle two U.S. investor lawsuits over its disclosures concerning the Enhance drug study released in early 2008.

Investors claimed they lost money when results of the study were published.

Merck said it has recorded a $493 million after-tax charge for the settlements. It said this reduced previously-reported fourth-quarter profit per share to 30 cents from 46 cents.

(Reporting by Jonathan Stempel in New York; Editing by Gerald E. McCormick)

(c) Copyright Thomson Reuters 2013. Check for restrictions at: http://about.reuters.com/fulllegal.asp

Discuss:

Discussion comments

,

Data: Latest rates in the US

Home equity rates View rates in your area
Home equity type Today +/- Chart
$30K HELOC FICO 4.99%
$30K home equity loan FICO 6.19%
$75K home equity loan FICO 5.91%
Credit card rates View more rates
Card type Today +/- Last Week
Low Interest Cards 10.93%
10.93%
Cash Back Cards 16.34%
16.34%
Rewards Cards 15.80%
15.80%
Source: Bankrate.com
  1. Jump to text

    (Reuters) - Merck & Co on Thursday said ...

  2. Jump to discussion

    Merck says to pay $688 million to settle Enhance...

  3. Jump to data

    See the latest rates around the country